Track the emergence and fate of impurities throughout drug development, attach all the relevant analytical data, and store searchable knowledge.
List view / Grid view
COVID-19 has affected nearly every Pharma industry. The development of a vaccine is challenging the world’s finest researchers and clinicians.
Learn why measuring binding affinity is key to helping you decide the next steps in your research and what technologies are available to measure it.
Biologics represent a growing class of drugs with indications in oncology, chronic inflammation, and autoimmune diseases.
Article: Immuno-oncology: Pushing the frontier of discovery through advanced high throughput flow cytometry
Immuno-oncology (IO) is increasingly prized as an effective therapy in cancer management.
Modulating the TCR signaling pathway using biologics, small molecules or genetic engineering is highly relevant to many therapeutic areas including cancer immunotherapy, adoptive cell therapy, vaccine development and autoimmune disease.
Learn how to measure protein stability, why it’s important, and what the key technologies are available to measure it.
Read application notes and best practices for optimised environmental detection and monitoring of airborne viruses with Coriolis® Air Samplers.
Best practices and optimised protocols with Precellys for high throughput sample preparation related to virus studies.
Application note: High-throughput pathogen detection using a novel MagMAX kit and OpenArray technology
Automated detection and isolation of pathogens for multiple samples types.
A simple and sensitive method for nucleic acid extraction from virus-containing samples, with a range of viral loads.
Isolate high-quality, inhibitor-free DNA and RNA from human stool and other sample types suitable for metagenomics sequencing.
Learn how fragment-based drug discovery improves hit rates and delivers higher-value targets using various biophysical methods.
Learn why researchers turned to biophysical methods to expose the molecular mechanisms of neurodegenerative diseases.
The identification and validation of novel drug targets is a challenging process for drug discovery programmes.